期刊文献+

Anatomical vs nonanatomical liver resection for solitary hepatocellular carcinoma:A systematic review and meta-analysis 被引量:5

下载PDF
导出
摘要 BACKGROUND The long-term survival of patients with solitary hepatocellular carcinoma(HCC)following anatomical resection(AR)vs non-anatomical resection(NAR)is still controversial.It is necessary to investigate which approach is better for patients with solitary HCC.AIM To compare perioperative and long-term survival outcomes of AR and NAR for solitary HCC.METHODS We performed a comprehensive literature search of PubMed,Medline(Ovid),Embase(Ovid),and Cochrane Library.Participants of any age and sex,who underwent liver resection,were considered following the following criteria:(1)Studies reporting AR vs NAR liver resection;(2)Studies focused on primary HCC with a solitary tumor;(3)Studies reporting the long-term survival outcomes(>5 years);and(4)Studies including patients without history of preoperative treatment.The main results were overall survival(OS)and disease-free survival(DFS).Perioperative outcomes were also compared.RESULTS A total of 14 studies,published between 2001 and 2020,were included in our meta-analysis,including 9444 patients who were mainly from China,Japan,and Korea.AR was performed on 4260(44.8%)patients.The synthetic results showed that the 5-year OS[odds ratio(OR):1.19;P<0.001]and DFS(OR:1.26;P<0.001)were significantly better in the AR group than in the NAR group.AR was associated with longer operating time[mean difference(MD):47.08;P<0.001],more blood loss(MD:169.29;P=0.001),and wider surgical margin(MD=1.35;P=0.04)compared to NAR.There was no obvious difference in blood transfusion ratio(OR:1.16;P=0.65)or postoperative complications(OR:1.24,P=0.18).CONCLUSION AR is superior to NAR in terms of long-term outcomes.Thus,AR can be recommended as a reasonable surgical option in patients with solitary HCC.
出处 《World Journal of Gastrointestinal Oncology》 SCIE 2021年第11期1833-1846,共14页 世界胃肠肿瘤学杂志(英文版)(电子版)
基金 Supported by National Key Technologies RD Program,No.2018YFC1106803 National Natural Science Foundation of China,No.81872004,No.81770615,and No.81672882 Science and Technology Support Program of Sichuan Province,No.2019YFQ0001 and No.2017SZ0003。
  • 相关文献

参考文献1

二级参考文献10

  • 1Hashem B. El-Serag.Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma[J]. Gastroenterology . 2012 (6)
  • 2Alejandro Forner,Josep M Llovet,Jordi Bruix.Hepatocellular carcinoma[J].The Lancet.2012(9822)
  • 3Yoshisato Tanimoto MD,Hirotaka Tashiro MD,Hiroshi Aikata MD,Hironobu Amano MD,Akihiko Oshita MD,Tsuyoshi Kobayashi MD,Shintaro Kuroda MD,Hirofumi Tazawa MD,Shoichi Takahashi MD,Toshiyuki Itamoto MD,Kazuaki Chayama MD,Hideki Ohdan MD.Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic Resection[J].Annals of Surgical Oncology.2012(2)
  • 4Mashaal Dhir,Elizabeth R. Lyden,Lynette M. Smith,Chandrakanth Are.Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta‐analysis[J].HPB.2012(9)
  • 5Yoshito Tomimaru,Hidetoshi Eguchi,Shigeru Marubashi,Hiroshi Wada,Shogo Kobayashi,Masahiro Tanemura,Koji Umeshita,Yuichiro Doki,Masaki Mori,Hiroaki Nagano.Equivalent Outcomes After Anatomical and Non-anatomical Resection of Small Hepatocellular Carcinoma in Patients with Preserved Liver Function[J].Digestive Diseases and Sciences.2012(7)
  • 6Pierce Kah‐HoeChow.Resection for hepatocellular carcinoma: Is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?[J].Journal of Gastroenterology and Hepatology.2012(3)
  • 7Andrea Ruzzenente,Alfredo Guglielmi,Marco Sandri,Tommaso Campagnaro,Alessandro Valdegamberi,Simone Conci,Fabio Bagante,Gianni Turcato,Mirko D’Onofrio,Calogero Iacono.Surgical Resection Versus Local Ablation for HCC on Cirrhosis: Results from a Propensity Case-Matched Study[J].Journal of Gastrointestinal Surgery.2012(2)
  • 8F. Cauchy,D. Fuks,J. Belghiti.HCC: current surgical treatment concepts[J].Langenbeck’s Archives of Surgery.2012(5)
  • 9Kheng-Choon Lim,Pierce Kah-Hoe Chow,John C. Allen,Ghim-Song Chia,Miaoshan Lim,Peng-Chung Cheow,Alexander Y.F. Chung,London L.P. Ooi,Say-Beng Tan.Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria[J].Annals of Surgery.2011(1)
  • 10Yukio Nakamura,Toru Mizuguchi,Masaki Kawamoto,Makoto Meguro,Kohei Harada,Shigenori Ota,Koichi Hirata.Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy[J].Surgery.2011(2)

共引文献14

同被引文献60

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部